Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2219359 | 0.91 | CHKA (0.61) | CHKACHKB | |
| Bromide SCHEMBL612817 | 0.87 | CHKA (0.61) | CHKACHKB | |
| SCHEMBL3164086 | 0.86 | CHKA (0.61) | CHKACHKB | |
| Bromide SCHEMBL2218782 | 0.78 | CHKA (0.61) | CHKACHKB | |
| Bromide SCHEMBL2217293 | 0.74 | CHKA (0.56) | CHKACHKB | |
| Bromide SCHEMBL2223549 | 0.73 | CHKA (0.53) | CHKACHKB | |
| Rsm-932A Cation SCHEMBL29616554 | 0.69 | CHKA (1.00) | CHKACHKB | |
| Rsm-932A Cation SCHEMBL16441051 | 0.68 | CHKA (1.00) | CHKACHKB | |
| Rsm-932A Cation SCHEMBL29941165 | 0.68 | CHKA (1.00) | CHKACHKB | |
| Bromide SCHEMBL2223547 | 0.67 | CHKA (1.00) | CHKACHKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586613-B2 | Pyridinium and quinolinium derivatives | UNIVERSIDAD DE GRANADA (ES) | 2013-11-19 | — | — | US | disclosed |
| US-20110178124-A1 | PYRIDINIUM AND QUINOLINIUM DERIVATIVES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2011-07-21 | — | — | US | disclosed |
| US-7781458-B2 | Derivatives of pyridine and quinoline | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2010-08-24 | — | — | US | disclosed |
| EP-1710236-B1 | DERIVATIVES OF PYRIDINE AND QUINOLINE | CONSEJO SUPERIOR INVESTIGACION (ES) | 2010-03-24 | — | — | EP | disclosed |
| EP-2085386-A2 | Pyridinium and quinolinium derivatives as Choline kinase inhibitors | Consejo Superior De Investigaciones Científicas (ES) | 2009-08-05 | — | — | EP | disclosed |
| US-20070185170-A1 | Derivatives of pyridine and quinoline | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185170-A1 | Derivatives of pyridine and quinoline | CHKA, CHKB, PHOSPHO1 | CHKA 1/4885CHKB 2/4885 |
| US-20110178124-A1 | PYRIDINIUM AND QUINOLINIUM DERIVATIVES | CHKA, PHOSPHO1, CHKB | CHKA 1/4885CHKB 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.